MedPath

Medical University of South Carolina

Medical University of South Carolina logo
🇺🇸United States
Ownership
Private
Established
1955-01-01
Employees
10K
Market Cap
-
Website
https://www.muschealth.com

Evaluation of Blink Tears and Systane Concomitant With Restasis for the Treatment of Dry Eye Symptoms

Not Applicable
Completed
Conditions
Dry Eye Syndrome
Interventions
First Posted Date
2007-11-30
Last Posted Date
2018-11-07
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
20
Registration Number
NCT00565669
Locations
🇺🇸

Medical University of South Carolina, Storm Eye Institute, Charleston, South Carolina, United States

Evaluation of the Aspheric ReSTOR Intraocular Lens (IOL) After Routine Cataract Extraction

Completed
Conditions
Cataract Extraction
Refractive Surgery
First Posted Date
2007-11-30
Last Posted Date
2010-10-04
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
20
Registration Number
NCT00565695
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Epidural Cortical Stimulation for Depression

Not Applicable
Active, not recruiting
Conditions
Treatment Resistant Depression
Interventions
Device: Synergy, Epidural cortical stimulation
First Posted Date
2007-11-30
Last Posted Date
2025-04-08
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
5
Registration Number
NCT00565617
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Acrysof Toric SN60T3corneal Astigmatism Between 0.75 and 1.00 D.

Not Applicable
Completed
Conditions
Cataracts
Interventions
Device: The Acrysof toric SN60T3 IOL
First Posted Date
2007-10-11
Last Posted Date
2018-07-24
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
4
Registration Number
NCT00542581
Locations
🇺🇸

Medical Unvirsity of South Carolina, Charleston, South Carolina, United States

An Open-Label Trial of N-Acetylcysteine in Cannabis Dependent Adolescents

Phase 1
Completed
Conditions
Cannabis Dependence
Interventions
First Posted Date
2007-10-11
Last Posted Date
2018-05-23
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
24
Registration Number
NCT00542750
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Blunt Needles do Not Reduce Needlestick Injuries to Doctors During Suturing After Child-Birth

Not Applicable
Completed
Conditions
Needlestick Injuries
Interventions
Device: Blunt needle
First Posted Date
2007-09-27
Last Posted Date
2007-09-27
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
438
Registration Number
NCT00536289
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

The Effect of Yohimbine on Cocaine Cue Reactivity

Phase 2
Completed
Conditions
Cocaine Related Disorders
Interventions
Drug: Placebo
First Posted Date
2007-09-26
Last Posted Date
2017-06-07
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
112
Registration Number
NCT00535002
Locations
🇺🇸

Medical University of South Carolina-GCRC, Charleston, South Carolina, United States

The Use of High Resolution Chest Computed Tomography in Alpha-1 Antitrypsin Deficiency

Completed
Conditions
Alpha-1 Antitrypsin Deficiency
First Posted Date
2007-09-20
Last Posted Date
2018-01-23
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
49
Registration Number
NCT00532805
Locations
🇺🇸

University of Florida Medical Center, Gainesville, Florida, United States

🇺🇸

Cleveland Clinic Foundation, Cleveland, Ohio, United States

🇺🇸

Cincinnati Children's Medical Center, Cincinnati, Ohio, United States

and more 4 locations

A Pilot Study of TMS Effects on Pain and Depression in Patients With Fibromyalgia

Not Applicable
Completed
Conditions
Fibromyalgia
Major Depression
Interventions
Device: Sham TMS
Device: Active TMS
First Posted Date
2007-08-31
Last Posted Date
2018-07-11
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
20
Registration Number
NCT00523302
Locations
🇺🇸

Medical University of South Carolina, Charleston, South Carolina, United States

Gemcitabine and Doxorubicin in Treating Patients With Recurrent or Progressive Head and Neck Cancer

Phase 2
Completed
Conditions
Head and Neck Cancer
Interventions
First Posted Date
2007-07-31
Last Posted Date
2018-07-12
Lead Sponsor
Medical University of South Carolina
Target Recruit Count
18
Registration Number
NCT00509665
Locations
🇺🇸

Hollings Cancer Center at Medical University of South Carolina, Charleston, South Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath